Expedition Therapeutics
PrivateLast Round
Series B
Aug 5, 2026
Est. Valuation
$650M
Total Funding Raised
$280M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Expedition Therapeutics is a biotechnology company developing novel therapies for serious inflammatory and respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expedition Therapeutics Comparables
Compare Expedition Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coultreon Biopharma | 74% | |
| GSK plc | 72% | |
| Slate Medicines | 71% | |
Expedition Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 5, 2026 | ||||
| Series A | Oct 9, 2025 |
Expedition Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balyasny Asset Management L.P. | Series A, Series B |
| RA Capital Management | Series B |
| Lake Bleu Capital | Series A |
| Forbion | Series A, Series B |
| Logos Capital | Series A, Series B |
| Novo Holdings | Series B, Series A |
| BVF Partners L.P. | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2026
$115M round led by General Atlantic.
- Jul 25, 2026
Monthly visitors increased 32% MoM.
Expedition Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Expedition Therapeutics's valuation, stock price, and market status.